Metabolic networks and metabolites underlie associations between maternal glucose during pregnancy and newborn size at birth

Diabetes

Volumn 65, Issue 7, 2016, Pages 2039-2050

  Scholtens, Denise M ^a   Bain, James R ^b,c   Reisetter, Anna C ^a   Muehlbauer, Michael J ^b,c   Nodzenski, Michael ^a   Stevens, Robert D ^b,c   Ilkayeva, Olga ^b,c   Lowe, Lynn P ^a   Metzger, Boyd E ^a   Newgard, Christopher B ^b,c   Lowe, William L ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; AMINO ACID; CARBOHYDRATE; CARBOXYLIC ACID; FATTY ACID; GLUCOSE; LIPID; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL;

ADULT; BIRTH WEIGHT; CONFERENCE PAPER; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTAKE; HUMAN; HYPERGLYCEMIA; LIPID METABOLISM; MALE; MASS FRAGMENTOGRAPHY; MATERNAL SERUM; METABOLISM; METABOLITE; METABOLOMICS; NEWBORN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; PREGNANCY; PRIORITY JOURNAL; PROGENY; BLOOD; BODY MASS; GLUCOSE TOLERANCE TEST; PHYSIOLOGY; PREGNANCY OUTCOME;

ADULT; BIRTH WEIGHT; BLOOD GLUCOSE; BODY MASS INDEX; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GLUCOSE TOLERANCE TEST; HUMANS; INFANT, NEWBORN; METABOLIC NETWORKS AND PATHWAYS; PREGNANCY; PREGNANCY OUTCOME; TRIGLYCERIDES;

EID: 84975840947     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db15-1748     Document Type: Conference Paper

References (50)

1. Metzger BE Long-term outcomes in mothers diagnosed with gestational diabetes mellitus and their offspring. Clin Obstet Gynecol 2007;50:972-979
2. Dabelea D, Crume T. Maternal environment and the transgenerational cycle of obesity and diabetes. Diabetes 2011;60:1849-1855
3. Catalano PM, Hauguel-De Mouzon S. Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic? Am J Obstet Gynecol 2011;204: 479-487
4. Metzger BE, Lowe LP, Dyer AR, et al.; HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358:1991-2002
5. Freinkel N. Banting Lecture 1980. Of pregnancy and progeny. Diabetes 1980;29:1023-1035
6. Haggarty P. Fatty acid supply to the human fetus. Annu Rev Nutr 2010;30: 237-255
7. Metzger BE Biphasic effects of maternal metabolism on fetal growth. Quintessential expression of fuel-mediated teratogenesis. Diabetes 1991; 40(Suppl. 2):99-105
8. Scholtens DM, Muehlbauer MJ, Daya NR, et al.; HAPO Study Cooperative Research Group. Metabolomics reveals broad-scale metabolic perturbations in hyperglycemic mothers during pregnancy. Diabetes Care 2014;37:158-166
9. Kind T, Wohlgemuth G, Lee Y, et al. FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry. Anal Chem 2009;81:10038-10048
10. Halket JM, Przyborowska A, Stein SE, Mallard WG, Down S, Chalmers RA. Deconvolution gas chromatography/mass spectrometry of urinary organic acidspotential for pattern recognition and automated identification of metabolic disorders. Rapid Commun Mass Spectrom 1999;13:279-284
11. Nodzenski M, Muehlbauer MJ, Bain JR, Reisetter AC, Lowe WL Jr, Scholtens DM. Metabomxtr: an R package for mixture-model analysis of non-targeted metabolomics data. Bioinformatics 2014;30:3287-3288
12. Benjamini Y, Hochberg Y. On the adaptive control of the false discovery rate in multiple testing with independent statistics. J Educ Behav Stat 2000;25:60-83
13. Xia J, Sinelnikov IV, Han B, Wishart DS. MetaboAnalyst 3.0-making metabolimics more meaningful. Nucleic Acids Res 2015;43:W251-W257
14. Kanehisa M, Sato Y, Kawashima M, Furumichi M, Tanabe M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res 2016; 44(D1):D457-D462
15. Goeman JJ, van de Geer SA, de Kort F, van Houwelingen HC. A global test for groups of genes: testing association with a clinical outcome. Bioinformatics 2004;20:93-99
16. Dittrich MT, Klau GW, Rosenwald A, Dandekar T, Müller T. Identifying functional modules in protein-protein interaction networks: an integrated exact approach. Bioinformatics 2008;24:i223-i231
17. Reichardt J, Bornholdt S. Statistical mechanics of community detection. Phys Rev E Stat Nonlin Soft Matter Phys 2006;74:016110
18. Csardi G, Nepusz T. The igraph software package for complex network research [Internet]. InterJournal, Complex Systems 1695 2006. Available at http://igraph.org. Accessed 27 October 2015
19. Breiman L. Random forests. Mach Learn 2001;45:5-32
20. Strobl C, Boulesteix AL, Kneib T, Augustin T, Zeileis A. Conditional variable importance for random forests. BMC Bioinformatics 2008;9:307
21. Ferrannini E, Natali A, Camastra S, et al. Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance. Diabetes 2013;62:1730-1737
22. Freinkel N, Metzger BE, Nitzan M, Daniel R, Surmaczynska B, Nagel T. Facilitated anabolism in late pregnancy: some novel maternal compensations for accelerated starvation. In Diabetes: Proceedings of the Eighth Congress of the International Diabetes Federation, Brussels, Belgium, 1973. Amsterdam, The Netherlands, Excerpta Medica International Congress Series, p. 474-488
23. Hadden DR, McLaughlin C. Normal and abnormal maternal metabolism during pregnancy. Semin Fetal Neonatal Med 2009;14:66-71
24. Butte NF Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr 2000;71(Suppl.):1256S-1261S
25. Huynh J, Xiong G, Bentley-Lewis R. A systematic review of metabolite profiling in gestational diabetes mellitus. Diabetologia 2014;57:2453-2464
26. Ho JE, Larson MG, Vasan RS, et al. Metabolite profiles during oral glucose challenge. Diabetes 2013;62:2689-2698
27. Geidenstam N, Spégel P, Mulder H, Filipsson K, Ridderstråle M, Danielsson AP. Metabolite profile deviations in an oral glucose tolerance test-a comparison between lean and obese individuals. Obesity (Silver Spring) 2014;22:2388-2395
28. Spegel P, Danielsson AP, Bacos K, et al. Metabolomic analysis of a human oral glucose tolerance test reveals fatty acids as reliable indicators of regulated metabolism. Metabolomics 2010;6:56-66
29. Bentley-Lewis R, Xiong G, Lee H, Yang A, Huynh J, Kim C. Metabolomic analysis reveals amino acid responses to an oral glucose tolerance test in women with prior history of gestational diabetes mellitus. J Clin Transl Endocrinol 2014; 1:38-43
30. Krug S, Kastenmüller G, Stückler F, et al. The dynamic range of the human metabolome revealed by challenges. FASEB J 2012;26:2607-2619
31. Zhao X, Peter A, Fritsche J, et al. Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at? Am J Physiol Endocrinol Metab 2009;296:E384-E393
32. Shaham O, Wei R, Wang TJ, et al. Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Mol Syst Biol 2008;4:214
33. Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest 2005; 115:485-491
34. Chen X, Scholl TO, Leskiw M, Savaille J, Stein TP. Differences in maternal circulating fatty acid composition and dietary fat intake in women with gestational diabetes mellitus or mild gestational hyperglycemia. Diabetes Care 2010;33: 2049-2054
35. Prentice KJ, Luu L, Allister EM, et al. The furan fatty acid metabolite CMPF is elevated in diabetes and induces β cell dysfunction. Cell Metab 2014;19:653-666
36. Dudzik D, Zorawski M, Skotnicki M, et al. Metabolic fingerprint of gestational diabetes mellitus. J Proteomics 2014;103:57-71
37. Enquobahrie DA, Denis M, Tadesse MG, Gelaye B, Ressom HW, Williams MA. Maternal early pregnancy serum metabolites and risk of gestational diabetes mellitus. J Clin Endocrinol Metab 2015;100:4348-4356
38. Kulkarni SR, Kumaran K, Rao SR, et al. Maternal lipids are as important as glucose for fetal growth: findings from the Pune Maternal Nutrition Study. Diabetes Care 2013;36:2706-2713
39. Schaefer-Graf UM, Graf K, Kulbacka I, et al. Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus. Diabetes Care 2008;31:1858-1863
40. Di Cianni G, Miccoli R, Volpe L, et al. Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance. Diabet Med 2005;22:21-25
41. Kushtagi P, Arvapally S. Maternal mid-pregnancy serum triglyceride levels and neonatal birth weight. Int J Gynaecol Obstet 2009;106:258-259
42. Knopp RH, Magee MS, Walden CE, Bonet B, Benedetti TJ. Prediction of infant birth weight by GDM screening tests. Importance of plasma triglyceride. Diabetes Care 1992;15:1605-1613
43. Kalhan SC Protein metabolism in pregnancy. Am J Clin Nutr 2000; 71(Suppl.):1249S-1255S
44. Schaefer-Graf UM, Meitzner K, Ortega-Senovilla H, et al. Differences in the implications of maternal lipids on fetal metabolism and growth between gestational diabetes mellitus and control pregnancies. Diabet Med 2011;28:1053-1059
45. Cetin I, de Santis MS, Taricco E, et al. Maternal and fetal amino acid concentrations in normal pregnancies and in pregnancies with gestational diabetes mellitus. Am J Obstet Gynecol 2005;192:610-617
46. McClain PE, Metcoff J, Crosby WM, Costiloe JP. Relationship of maternal amino acid profiles at 25 weeks of gestation to fetal growth. Am J Clin Nutr 1978; 31:401-407
47. Kalkhoff RK, Kandaraki E, Morrow PG, Mitchell TH, Kelber S, Borkowf HI. Relationship between neonatal birth weight and maternal plasma amino acid profiles in lean and obese nondiabetic women and in type I diabetic pregnant women. Metabolism 1988;37:234-239
48. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010;107:1058-1070
49. Park S, Park JY, Lee JH, Kim SH. Plasma levels of lysine, tyrosine, and valine during pregnancy are independent risk factors of insulin resistance and gestational diabetes. Metab Syndr Relat Disord 2015;13:64-70
50. Butte NF, Hsu HW, Thotathuchery M, Wong WW, Khoury J, Reeds P. Protein metabolism in insulin-treated gestational diabetes. Diabetes Care 1999;22:806-811